PAPER Ma T
SEARCH RESULTS
329963 RESULTS
PAPER Alcolea D, Martínez-Lage P, Izagirre A, Clerigué M, Carmona-Iragui M, Alvarez RM, Fortea J, Balasa M, Morenas-Rodríguez E, Lladó A, Grau O, Blennow K, Lleó A, Molinuevo JL
Feasibility of lumbar puncture in the study of cerebrospinal fluid biomarkers for Alzheimer's disease: a multicenter study in Spain.
J Alzheimers Dis. 2014;39(4):719-26. PubMed: 24254700PAPER Nagata T, Kobayashi N, Shinagawa S, Yamada H, Kondo K, Nakayama K
Plasma BDNF levels are correlated with aggressiveness in patients with amnestic mild cognitive impairment or Alzheimer disease.
J Neural Transm. 2014 Apr;121(4):433-41. Epub 2013 Nov 20 PubMed: 24253237PAPER Aboud O, Mrak RE, Boop FA, Griffin WS
Epilepsy: neuroinflammation, neurodegeneration, and APOE genotype.
Acta Neuropathol Commun. 2013 Jul 29;1(1):41. PubMed: 24252240PAPER Fu JL, Liu Y, Li YM, Chang C, Li WB
Use of Diffusion Tensor Imaging for Evaluating Changes in the Microstructural Integrity of White Matter Over 3 Years in Patients with Amnesic-Type Mild Cognitive Impairment Converting to Alzheimer's Disease.
J Neuroimaging. 2013 Nov 19; PubMed: 24251793PAPER Spies PE, Verbeek MM, Sjogren MJ, de Leeuw FE, Claassen JA
Alzheimer biomarkers and clinical Alzheimer disease were not associated with increased cerebrovascular disease in a memory clinic population.
Curr Alzheimer Res. 2014 Jan;11(1):40-6. PubMed: 24251395PAPER Sopova K, Gatsiou K, Stellos K, Laske C
Dysregulation of neurotrophic and haematopoietic growth factors in Alzheimer's disease: from pathophysiology to novel treatment strategies.
Curr Alzheimer Res. 2014 Jan;11(1):27-39. PubMed: 24251394PAPER Gilat-Frenkel M, Boehm-Cagan A, Liraz O, Xian X, Herz J, Michaelson DM
Involvement of the Apoer2 and Lrp1 receptors in mediating the pathological effects of ApoE4 in vivo.
Curr Alzheimer Res. 2013 Nov 19; PubMed: 24251389PAPER Briones TL, Woods J, Rogozinska M
Decreased neuroinflammation and increased brain energy homeostasis following environmental enrichment after mild traumatic brain injury is associated with improvement in cognitive function.
Acta Neuropathol Commun. 2013 Sep 6;1(1):57. PubMed: 24252176PAPER Wang M, Li F, Shi Z, Liu Y, Wang X, Li L, Gao D
N-cadherin is a novel ERα anchor that protects against 6-OHDA damage to dopaminergic cells.
Cell Mol Neurobiol. 2014 Jan;34(1):123-31. Epub 2013 Nov 20 PubMed: 24254198PAPER Sacino AN, Brooks M, McGarvey NH, McKinney AB, Thomas MA, Levites Y, Ran Y, Golde TE, Giasson BI
Induction of CNS α-synuclein pathology by fibrillar and non-amyloidogenic recombinant α-synuclein.
Acta Neuropathol Commun. 2013 Jul 17;1(1):38. PubMed: 24252149PAPER Visanji NP, Brooks PL, Hazrati LN, Lang AE
The prion hypothesis in Parkinson's disease: Braak to the future.
Acta Neuropathol Commun. 2013 May 8;1(1):2. PubMed: 24252164PAPER Wilens TE, Waxmonsky J, Scott M, Swezey A, Kwon A, Spencer TJ, Biederman J
An open trial of adjunctive donepezil in attention-deficit/hyperactivity disorder.
J Child Adolesc Psychopharmacol. 2005 Dec;15(6):947-55. PubMed: 16379515PAPER Fillit H, Gutterman EM, Lewis B
Donepezil use in managed Medicare: effect on health care costs and utilization.
Clin Ther. 1999 Dec;21(12):2173-85. PubMed: 10645761PAPER
Abstracts of the 6th Congress of the European Federation of Neurological Societies. Vienna, Austria, October 26-29, 2002.
Eur J Neurol. 2002 Oct;9 Suppl 2:1-265. PubMed: 12656064Current Filters
No filters selected